PHARMACYTE BIOTECH, INC. (PMCB) Total liabilities 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) total liabilities at each fiscal year-end, per SEC filings.
$11.8MFY2026 · since FY2017: $580,248 → $11.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $11.8M | +259.2% |
| FY2025 | $3.3M | -83.9% |
| FY2024 | $20.4M | +3376.0% |
| FY2023 | $586,581 | -16.7% |
| FY2022 | $704,370 | -2.8% |
| FY2021 | $724,778 | -32.7% |
| FY2020 | $1.1M | +45.1% |
| FY2019 | $742,851 | +15.3% |
| FY2018 | $644,168 | +11.0% |
| FY2017 | $580,248 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice